Israeli bio-insecticide startup secures $6.1m series A
Ibi Ag develops bio-insecticides using single-domain antibody technology from the pharmaceutical sector…
Ibi Ag develops bio-insecticides using single-domain antibody technology from the pharmaceutical sector…
Read More